annual current liabilities:
$1.13B+$283.18M(+33.45%)Summary
- As of today (September 18, 2025), AMRX annual total current liabilities is $1.13 billion, with the most recent change of +$283.18 million (+33.45%) on December 31, 2024.
- During the last 3 years, AMRX annual current liabilities has risen by +$452.53 million (+66.82%).
- AMRX annual current liabilities is now at all-time high.
Performance
AMRX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.11B+$31.31M(+2.91%)Summary
- As of today (September 18, 2025), AMRX quarterly total current liabilities is $1.11 billion, with the most recent change of +$31.31 million (+2.91%) on June 30, 2025.
- Over the past year, AMRX quarterly current liabilities has dropped by -$7.22 million (-0.65%).
- AMRX quarterly current liabilities is now -2.00% below its all-time high of $1.13 billion, reached on December 31, 2024.
Performance
AMRX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AMRX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | -0.7% |
| 3 y3 years | +66.8% | +11.5% |
| 5 y5 years | +105.3% | +69.0% |
AMRX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.8% | -2.0% | +57.3% |
| 5 y | 5-year | at high | +105.3% | -2.0% | +83.9% |
| alltime | all time | at high | >+9999.0% | -2.0% | >+9999.0% |
AMRX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.11B(+2.9%) |
| Mar 2025 | - | $1.08B(-4.8%) |
| Dec 2024 | $1.13B(+33.4%) | $1.13B(+3.2%) |
| Sep 2024 | - | $1.10B(-1.7%) |
| Jun 2024 | - | $1.11B(+33.6%) |
| Mar 2024 | - | $834.39M(-1.4%) |
| Dec 2023 | $846.60M(+12.5%) | $846.60M(+11.3%) |
| Sep 2023 | - | $760.60M(-2.2%) |
| Jun 2023 | - | $777.35M(+10.5%) |
| Mar 2023 | - | $703.71M(-6.5%) |
| Dec 2022 | $752.80M(+11.2%) | $752.80M(-8.0%) |
| Sep 2022 | - | $818.00M(-17.6%) |
| Jun 2022 | - | $993.06M(+64.9%) |
| Mar 2022 | - | $602.04M(-11.1%) |
| Dec 2021 | $677.24M(+0.1%) | $677.24M(+1.5%) |
| Sep 2021 | - | $667.34M(-0.8%) |
| Jun 2021 | - | $672.86M(+5.7%) |
| Mar 2021 | - | $636.78M(-5.9%) |
| Dec 2020 | $676.90M(+23.0%) | $676.90M(+1.3%) |
| Sep 2020 | - | $667.89M(+2.0%) |
| Jun 2020 | - | $655.02M(-32.1%) |
| Mar 2020 | - | $965.07M(+75.3%) |
| Dec 2019 | $550.41M(-0.6%) | $550.41M(+2.9%) |
| Sep 2019 | - | $534.91M(-2.1%) |
| Jun 2019 | - | $546.16M(-8.9%) |
| Mar 2019 | - | $599.53M(+8.2%) |
| Dec 2018 | $553.85M(+86.6%) | $553.85M(-26.1%) |
| Sep 2018 | - | $749.27M(+11.9%) |
| Jun 2018 | - | $669.74M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $296.88M(-7.6%) | $296.88M(-7.6%) |
| Dec 2016 | $321.32M(-1.7%) | - |
| Dec 2016 | - | $321.32M(-3.9%) |
| Sep 2016 | - | $334.53M(+25.8%) |
| Jun 2016 | - | $265.95M(-12.1%) |
| Mar 2016 | - | $302.55M(-7.4%) |
| Dec 2015 | $326.76M(+105.9%) | $326.76M(+38.8%) |
| Sep 2015 | - | $235.49M(+3.9%) |
| Jun 2015 | - | $226.57M(-7.4%) |
| Mar 2015 | - | $244.64M(+54.2%) |
| Dec 2014 | $158.70M(+3.1%) | $158.70M(-6.7%) |
| Sep 2014 | - | $170.15M(+8.8%) |
| Jun 2014 | - | $156.35M(+26.9%) |
| Mar 2014 | - | $123.22M(-19.9%) |
| Dec 2013 | $153.89M(+5.9%) | $153.89M(-6.8%) |
| Sep 2013 | - | $165.08M(-1.4%) |
| Jun 2013 | - | $167.39M(-6.1%) |
| Mar 2013 | - | $178.20M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $145.29M(-7.4%) | $145.29M(-20.7%) |
| Sep 2012 | - | $183.23M(-32.8%) |
| Jun 2012 | - | $272.84M(+13.2%) |
| Mar 2012 | - | $241.01M(+53.6%) |
| Dec 2011 | $156.86M(+24.1%) | $156.86M(+13.8%) |
| Sep 2011 | - | $137.88M(-3.4%) |
| Jun 2011 | - | $142.76M(+5.5%) |
| Mar 2011 | - | $135.36M(+7.1%) |
| Dec 2010 | $126.42M(-38.0%) | $126.42M(-25.1%) |
| Sep 2010 | - | $168.85M(-51.8%) |
| Jun 2010 | - | $350.14M(+39.3%) |
| Mar 2010 | - | $251.33M(+23.3%) |
| Dec 2009 | $203.87M(+85.6%) | $203.87M(+87.1%) |
| Sep 2009 | - | $108.97M(+10.6%) |
| Jun 2009 | - | $98.54M(-2.7%) |
| Mar 2009 | - | $101.31M(-7.8%) |
| Dec 2008 | $109.83M(-31.5%) | $109.83M(+11.6%) |
| Sep 2008 | - | $98.41M(-34.2%) |
| Jun 2008 | - | $149.47M(-6.8%) |
| Dec 2007 | $160.35M(+62.4%) | $160.35M(+62.4%) |
| Dec 2006 | $98.75M(+35.1%) | $98.75M(+207.4%) |
| Dec 2005 | $73.08M(+72.5%) | - |
| Sep 2004 | - | $32.12M(-18.9%) |
| Jun 2004 | - | $39.60M(-28.8%) |
| Mar 2004 | - | $55.64M(+31.3%) |
| Dec 2003 | $42.37M(+82.2%) | $42.37M(+36.9%) |
| Sep 2003 | - | $30.95M(+19.8%) |
| Jun 2003 | - | $25.84M(-4.8%) |
| Mar 2003 | - | $27.14M(+16.8%) |
| Dec 2002 | $23.25M(+197.9%) | $23.25M(+128.8%) |
| Sep 2002 | - | $10.16M(+6.1%) |
| Jun 2002 | - | $9.58M(-5.9%) |
| Mar 2002 | - | $10.18M(+30.4%) |
| Dec 2001 | $7.80M(+19.9%) | $7.80M(+19.9%) |
| Sep 2001 | - | $6.51M(+32.6%) |
| Jun 2001 | - | $4.91M(-2.2%) |
| Mar 2001 | - | $5.02M(-22.9%) |
| Dec 2000 | $6.51M(-12.3%) | $6.51M(-24.8%) |
| Sep 2000 | - | $8.65M(-9.5%) |
| Jun 2000 | - | $9.56M(+12.9%) |
| Mar 2000 | - | $8.47M(+14.2%) |
| Dec 1999 | $7.42M(+154.8%) | $7.42M(+57.1%) |
| Sep 1999 | - | $4.72M(+28.4%) |
| Jun 1999 | - | $3.68M(+1.0%) |
| Mar 1999 | - | $3.64M(+25.0%) |
| Dec 1998 | $2.91M | $2.91M(+39.9%) |
| Sep 1998 | - | $2.08M(+51.5%) |
| Jun 1998 | - | $1.37M(-9.4%) |
| Mar 1998 | - | $1.52M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of AMRX is $1.13B
What is the all time high annual current liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total current liabilities is $1.13B
What is Amneal Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, AMRX annual total current liabilities has changed by +$283.18M (+33.45%)
What is Amneal Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of AMRX is $1.11B
What is the all time high quarterly current liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $1.13B
What is Amneal Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, AMRX quarterly total current liabilities has changed by -$7.22M (-0.65%)